REG - BkofA Merrill Lynch Horizon Therapeutics - HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA

AmgenAnnouncement

12/01/2023 11:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230112:nRSL5517Ma&default-theme=true

RNS Number : 5517M  Bank of America Merrill Lynch  12 January 2023

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT

RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY

STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 1.  KEY INFORMATION

 Name of exempt principal trader             Bank of America, N.A., Proprietary
 Company dealt in                            HORIZON THERAPEUTICS PLC
 Class of relevant security to which the     Common - IE00BQPVQZ61

dealings being disclosed relate(Note 1)
 Date of dealing                             11/01/2023

Bank of America, N.A., Proprietary

 Company dealt in

HORIZON THERAPEUTICS PLC

 Class of relevant security to which the

dealings being disclosed relate(Note 1)

Common - IE00BQPVQZ61

 Date of dealing

11/01/2023

 

 2.  INTERESTS AND SHORT POSITIONS

 (a)  Interests and short positions (following dealing) in the class of relevant
      security

dealt in (Note 2)

 Class of relevant security: Common             IE00BQPVQZ61
                                                Long             Short
                                                Number   %       Number   %
 (1)  Relevant securities                       434,923  0.192%  0        0 %
 (2)  Derivatives (other than options):         18,577   0.008%  359,246  0.158%
 (3)  Options and agreements to purchase/sell:  0        0%      0        0%
 Total                                          453,500  0.2%    359,246  0.158%

434,923

0.192%

0

0 %

 (2)  Derivatives (other than options):

18,577

0.008%

359,246

0.158%

 (3)  Options and agreements to purchase/sell:

0

0%

0

0%

Total

453,500

0.2%

359,246

0.158%

 

 (b)  Interests and short positions in relevant securities of the company, other
      than the

class dealt in (Note 2)

 Class of relevant security:
                                                Long         Short
                                                Number  %    Number  %
 (1)  Relevant securities                       0       0%   0       0%
 (2)  Derivatives (other than options):         0       0%   0       0%
 (3)  Options and agreements to purchase/sell:  0       0%   0       0%
 Total                                          0       0%   0       0%

0

0%

0

0%

 (2)  Derivatives (other than options):

0

0%

0

0%

 (3)  Options and agreements to purchase/sell:

0

0%

0

0%

Total

0

0%

0

0%

 3.  DEALINGS (Note 3)

 (a)  Purchases and sales

 Purchase/sale  Number of relevant securities  Price per unit (Note 4)
 Purchase               104                    113.06 USD
 Purchase               102                    113.1 USD
 Purchase                 60                   113.102 USD
 Purchase                 89                   113.107 USD
 Purchase                 39                   113.108 USD
 Purchase               157                    113.11 USD
 Purchase                 40                   113.111 USD
 Purchase               126                    113.113 USD
 Purchase                 59                   113.114 USD
 Purchase                 37                   113.117 USD
 Purchase            3,054                     113.12 USD
 Purchase                 49                   113.121 USD
 Purchase                 49                   113.122 USD
 Purchase                 61                   113.124 USD
 Purchase                 47                   113.129 USD
 Purchase               101                    113.13 USD
 Purchase                 27                   113.132 USD
 Purchase                 57                   113.135 USD
 Purchase                 60                   113.138 USD
 Purchase               111                    113.139 USD
 Purchase               377                    113.14 USD
 Purchase                 57                   113.141 USD
 Purchase                 39                   113.142 USD
 Purchase               114                    113.143 USD
 Purchase               130                    113.144 USD
 Purchase               168                    113.145 USD
 Purchase                 67                   113.146 USD
 Purchase            6,000                     113.147 USD
 Purchase                 43                   113.148 USD
 Purchase                 86                   113.149 USD
 Purchase               401                    113.15 USD
 Purchase                 61                   113.151 USD
 Purchase                 71                   113.152 USD
 Purchase                 67                   113.153 USD
 Purchase               174                    113.154 USD
 Purchase                 93                   113.156 USD
 Purchase                 28                   113.158 USD
 Purchase               188                    113.16 USD
 Purchase                 35                   113.161 USD
 Purchase                 26                   113.163 USD
 Purchase                 25                   113.164 USD
 Purchase                 30                   113.165 USD
 Purchase                 28                   113.166 USD
 Purchase               196                    113.17 USD
 Purchase                 24                   113.172 USD
 Purchase                 26                   113.174 USD
 Purchase                 35                   113.176 USD
 Purchase                 31                   113.177 USD
 Purchase                 38                   113.183 USD
 Purchase                 35                   113.191 USD
 Purchase                 36                   113.198 USD
 Purchase                 23                   113.199 USD

 

 Purchase/sale  Number of relevant securities  Price per unit (Note 4)
 Sale                   104                    113.06 USD
 Sale                      6                   113.12 USD

 

 (b)  Derivatives transactions (other than options transactions)

 Product name,  Nature of transaction        Number of relevant securities  Price per unit

e.g. CFD
(Note 5)                    (Note 6)
(Note 4)
 Swaps          Increasing a Short Position  6,000                          113.152 USD

 

 (c)  Options transactions in respect of existing relevant securities

 (i)  Writing, selling, purchasing or varying

 Product name, e.g. call option  Writing, selling, purchasing, varying etc.  Number of securities to which the option relates (Note 7)  Exercise price  Type, e.g. American, European etc  Expiry date  Option money paid/ received per unit (Note 4)
 N/A                             N/A                                         N/A                                                        N/A             N/A                                N/A          N/A

 

 (ii)  Exercising

 Product name,      Number of securities  Exercise price per

e.g. call option
unit (Note 4)
 N/A                N/A                   N/A

 

 (d)  Other dealings (including transactions in respect of new securities) (Note 3)

 Nature or transaction  Details  Price per unit
 (Note 7)
(if applicable) (Note 4)
 N/A                    N/A      N/A

 

 4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 Full details of any agreement, arrangement or understanding between the person

disclosing and any other person relating to the voting rights of any relevant

securities under any option referred to on this form or relating to the voting
 rights

or future acquisition or disposal of any relevant securities to which any
 derivative

referred to on this form is referenced. If none, this should be stated.
 None

 

 Is a Supplemental Form 38.5(b) attached? (Note 8)  No

 

 Date of disclosure                            12/01/2023
 Contact name                                  Frank Lui
 Telephone number                              +44207 996 6418
 Name of offeree/offeror with which connected  AMGEN INC
 Nature of connection (Note 9)                 Advisor to - AMGEN INC

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEBTMMTMTJBBAJ